Provided is the use of ingenol derivative compounds of formula I, wherein the variables are as defined in the specification, to reactivate latent HIV. This allows the treatment of HIV/AIDS by anti-retroviral agents active against actively replicating viruses. Further provided is a pharmaceutical composition comprising an ingenol derivative of formula I and an anti-retroviral agent active against actively replicating viruses.